Biotech Values

[DewDiligence]

IDIX had a good presentation today at the DB conference. For a CFO, Ron Renaud talks a good game when discussing such matters as first-step phosphorylation and complementary resistance profiles. It helped that the CSO, David Standring, was also at the presentation to add some color and participate in the Q&A.

The 30-minute webcast can be accessed at:
http://phx.corporate-ir.net/phoenix.zhtml?c=128651&p=conferenceAgenda&id=1927570&day=1
in the rightmost column of the second row.